Drug Profile
Technetium-99m depreotide - Bayer HealthCare Pharmaceuticals
Alternative Names: Depreotide trifluoroacetate; NeoSpect; NeoTect; P 829; Tc 99m P 829Latest Information Update: 15 Jun 2015
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Class Imaging agents; Organotechnetium compounds; Peptides; Radiopharmaceutical diagnostics; Radiopharmaceuticals; Small molecules
- Mechanism of Action Image enhancers
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Market Withdrawal Lung cancer
Most Recent Events
- 15 Jun 2015 Withdrawn for Lung cancer (Diagnosis) in Middle East (IV) before June 2015
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer HealthCare Pharmaceuticals
- 29 Dec 2006 Schering AG is now called Bayer Schering Pharma AG